We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 2,248

Do-gooders need not apply

  • Pepper Hamilton LLP
  • -
  • USA
  • -
  • October 21 2014

According to its mission statement, Consumer Watchdog is a non-profit entity "dedicated to providing an effective voice for taxpayers and consumers in

IPR challenge to pharmaceutical compound patent denied

  • Armstrong Teasdale LLP
  • -
  • USA
  • -
  • October 20 2014

On October 1, 2014, the PTAB denied a petition for inter partes review in Torrent Pharmaceuticals, Limited v. Merck Frosst Canada & Co. (Case

Supreme Court: should appeal give deference to lower courts on claim construction?

  • Reed Smith LLP
  • -
  • USA
  • -
  • October 17 2014

On October 15, the Supreme Court heard oral argument in Teva Pharmaceuticals USA Inc., et al. V. Sandoz Inc., et al., case number 13-854. At issue is

Personalized medicine: patent issues in Canada and Europe

  • Gowling Lafleur Henderson LLP
  • -
  • Canada, European Union
  • -
  • October 16 2014

Canada Introduction 'Personalized medicine', in its broadest aspects, is essentially the tailoring of treatments to individual characteristics, needs

Appealing medical device patent cases

  • Knobbe Martens Olson & Bear LLP
  • -
  • USA
  • -
  • October 15 2014

Medical device patent infringement cases, like all patent infringement cases, must be appealed to the U.S. Court of Appeals for the Federal Circuit

Supreme Court hears oral argument in Teva Pharmaceuticals v. Sandoz

  • Fitzpatrick, Cella, Harper & Scinto
  • -
  • USA
  • -
  • October 15 2014

On October 15, 2014, the Supreme Court of the United States heard oral argument in Teva Pharmaceuticals USA, Inc., et al. V. Sandoz, Inc., et al., No

Patent not eligible for listing: patent claiming one medicinal ingredient,but directed to a fixed-dose combination of medicines

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 15 2014

This was an appeal from two decisions for three proceedings before Prothonotary Milczynski, in which she determined that a patent could not be listed

SCOTUS: Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.

  • Frommer Lawrence & Haug LLP
  • -
  • USA
  • -
  • October 15 2014

The case of Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. was argued on October 15, 2014 in the Untied States Supreme Court. Our best read is that

Costa Rican Patent Office position as to Swiss type claims

  • CastroPal Abogados
  • -
  • Costa Rica
  • -
  • October 14 2014

According to the Costa Rican Patent Law, methods of treatment or diagnosis are considered non- patentable subject matter in Costa Rica, as well as

Canadian Competition Bureau provides preliminary guidance on pharma patent settlements

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • October 14 2014

Settlements of patent litigation between brand name and generic pharmaceutical companies have been the subject of significant antitrustcompetition